# US 2008/0076117 A1 · Socs-1 gene methylation in cancer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0076117 A1
- Document ID: US20080076117A1
- Status: Published application
- Kind: A1
- Application number: 10/123,882
- Filed: 2002-04-15
- Published: 2008-03-27
- Earliest claimed: 2001-04-13
- Assignees: The Johns Hopkins University School of Medicine
- Inventors: James G. Herman; Hirohide Yoshikawa; Curtis C. Harris
- Web page: https://patentgrep.com/patent/US20080076117A1

## CPC

- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- C12Q 2523/125: Bisulfite(s)
- C12Q 2600/112: Disease subtyping, staging or classification
- C12Q 2600/154: Methylation markers
- C12Q 2600/16: Primer sets for multiplex assays
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Methods are provided for identifying a cell exhibiting unregulated growth associated with methylation-silenced transcription of a suppressor of cytokine signaling (SOCS)/cytokine-inducible SH2 protein (CIS) family member (SOCS/CIS) gene such as the SOCS-1 gene. In addition, methods of treating a cancer patient, wherein cancer cells in the patient exhibit methylation-silenced transcription of SOCS/CIS gene such as a SOCS-1 gene, are provided, as are reagents for practicing such methods.

## Claims

### Claim at position 1

-6. (canceled)

### Claim 7

A method for identifying a neoplastic cell, which exhibits unregulated growth, comprising detecting methylation of a cytosine residue of a CpG dinucleotide in a CpG island of a suppressor of cytokine signaling-1 (SOCS-1) gene in a sample comprising a test cell, or an extract thereof, wherein detecting methylation comprises:
contacting a nucleic acid molecule comprising the SOCS-1 of the test cell with bisulfite ions, whereby unmethylated cytosine residues in the SOCS-1 gene sequence are converted to bisulfite modified cytosine residues;
exposing the bisulfite ion treated SOCS-1 gene sequence to alkaline conditions, whereby bisulfite modified cytosine residues are converted to uracil residues;
contacting the bisulfite ion treated SOCS-1 gene sequence with an amplification primer pair under conditions suitable for amplification, wherein the amplification primer pair comprises SEQ ID NO:6 and SEQ ID NO:7; SEQ ID NO:12 and SEQ ID NO:13; SEQ ID NO:14 and SEQ ID NO:15; or SEQ ID NO:16 and SEQ ID NO:17; and
determining the nucleotide sequence of the amplification product, thereby detecting the amount or distribution of uracil residues in the bisulfite ion treated SOCS-1 gene of the test cell,
wherein a decrease in the amount or distribution of uracil residues in the SOCS-1 gene from the test cell, as compared to the amount or distribution of uracil residues in a corresponding bisulfite ion treated unmethylated SOCS-1 gene following exposure to alkaline conditions, is indicative of methylation of cytosine residues in CpG dinucleotides in the SOCS-1 gene of the test cell,
and wherein said methylation results in a reduced level of transcription of the SOCS-1 gene in the test cell as compared to a corresponding normal cell,
thereby identifying the test cell as a neoplastic cell.

### Claim 8

A method for identifying a neoplastic cell, which exhibits unregulated growth, comprising detecting methylation of a cytosine residue of a CpG dinucleotide in a CpG island of a suppressor of cytokine signaling-1 (SOCS-1) gene in a sample comprising a test cell, or an extract thereof, wherein detecting methylation comprises:
contacting a nucleic acid molecule comprising the SOCS-1 of the test cell with bisulfite ions, whereby unmethylated cytosine residues in the SOCS-1 gene sequence are converted to bisulfite modified cytosine residues;
exposing the bisulfite ion treated SOCS-1 gene sequence to alkaline conditions, whereby bisulfite modified cytosine residues are converted to uracil residues;
contacting the bisulfite ion treated SOCS-1 gene sequence with an oligonucleotide that selectively hybridizes to a SOCS-1 gene sequence, containing uracil residues; and
detecting selective hybridization of the oligonucleotide, thereby detecting the amount or distribution of uracil residues in the bisulfite ion treated SOCS-1 gene of the test cell,
wherein a decrease in the amount or distribution of uracil residues in the SOCS-1 gene from the test cell, as compared to the amount or distribution of uracil residues in a corresponding bisulfite ion treated unmethylated SOCS-1 gene following exposure to alkaline conditions, is indicative of methylation of cytosine residues in CpG dinucleotides in the SOCS-1 gene of the test cell,
and wherein said methylation results in a reduced level of transcription of the SOCS-1 gene in the test cell as compared to a corresponding normal cell,
thereby identifying the test cell as a neoplastic cell.

### Claim 9 (depends on 8)

The method of claim 8, wherein the oligonucleotide comprises a detectable label, and wherein detecting selective hybridization comprises detecting the label.

### Claim 10 (depends on 8)

The method of claim 8, wherein the oligonucleotide is a substrate for a primer extension reaction, and wherein detecting selective hybridization comprises detecting a product of the primer extension reaction.

### Claim 11 (depends on 10)

The method of claim 10, wherein the oligonucleotide comprises a nucleotide sequence as set forth in SEQ ID NO:2.

### Claim 12

A method for identifying a neoplastic cell, which exhibits unregulated growth, comprising detecting methylation of a cytosine residue of a CpG dinucleotide in a CpG island of a suppressor of cytokine signaling-1 (SOCS-1) gene in a sample comprising a test cell, or an extract thereof, wherein detecting methylation comprises:
contacting a nucleic acid molecule comprising the SOCS-1 of the test cell with bisulfite ions, whereby unmethylated cytosine residues in the SOCS-1 gene sequence are converted to bisulfite modified cytosine residues;
exposing the bisulfite ion treated SOCS-1 gene sequence to alkaline conditions, whereby bisulfite modified cytosine residues are converted to uracil residues; and
detecting the amount or distribution of uracil residues in the bisulfite ion treated SOCS-1 gene of the test cell, wherein detecting the amount or distribution of uracil residues comprises
contacting the SOCS-1 gene sequence with an amplification primer pair comprising a forward primer and a reverse primer under conditions suitable for amplification, wherein at least one of the forward primer and the reverse primer comprises an oligonucleotide that selectively hybridizes to a SOCS-1 gene sequence containing uracil residues, whereby generation of an amplification product is indicative of lack of methylation of cytosine residues in CpG dinucleotides in the SOCS-1 gene of the test cell,
wherein a decrease in the amount or distribution of uracil residues in the SOCS-1 gene from the test cell, as compared to the amount or distribution of uracil residues in a corresponding bisulfite ion treated unmethylated SOCS-1 gene following exposure to alkaline conditions, is indicative of methylation of cytosine residues in CpG dinucleotides in the SOCS-1 gene of the test cell,
and wherein said methylation results in a reduced level of transcription of the SOCS-1 gene in the test cell as compared to a corresponding normal cell, thereby identifying the test cell as a neoplastic cell.

### Claim 13 (depends on 12)

The method of claim 12, wherein the amplification primer pair comprises SEQ ID NO:2 and SEQ ID NO:3.

### Claim 14

A method for identifying a neoplastic cell, which exhibits unregulated growth, comprising detecting methylation of a cytosine residue of a CpG dinucleotide in a CpG island of a suppressor of cytokine signaling-1 (SOCS-1) gene in a sample comprising a test cell, or an extract thereof, wherein the detecting methylation comprises:
contacting a nucleic acid molecule comprising the SOCS-1 of the test cell with bisulfite ions, whereby unmethylated cytosine residues in the SOCS-1 gene sequence are converted to bisulfite modified cytosine residues;
exposing the bisulfite ion treated SOCS-1 gene sequence to alkaline conditions, whereby bisulfite modified cytosine residues are converted to uracil residues; and
detecting the amount or distribution of uracil residues in the bisulfite ion treated SOCS-1 gene of the test cell, wherein detecting the amount or distribution of uracil residues comprises contacting the SOCS-1 gene sequence with an amplification primer pair comprising a forward primer and a reverse primer under conditions suitable for amplification, wherein each of the forward primer and the reverse primer selectively hybridizes to a SOCS-1 gene sequence containing uracil residues, but not to a SOCS-1 gene sequence containing cytosine residues, whereby generation of an amplification product is indicative of a lack of methylation of cytosine residues in CpG dinucleotides in the SOCS-1 gene of the test cell,
wherein a decrease in the amount or distribution of uracil residues in the SOCS-1 gene from the test cell, as compared to the amount or distribution of uracil residues in a corresponding bisulfite ion treated unmethylated SOCS-1 gene following exposure to alkaline conditions, is indicative of methylation of cytosine residues in CpG dinucleotides in the SOCS-1 gene of the test cell,
an wherein said methylation results in a reduced level of transcription of the SOCS-1 gene in the test cell as compared to a corresponding normal cell,
thereby identifying the test cell as a neoplastic cell.

### Claim 15 (depends on 14)

The method of claim 14, wherein the amplification primer pair comprises SEQ ID NO:4 and SEQ ID NO:5.

### Claim 16

A method for identifying a neoplastic cell, which exhibits unregulated growth, comprising detecting methylation of a cytosine residue of a CpG dinucleotide in a CpG island of a suppressor of cytokine signaling-1 (SOCS-1) gene in a sample comprising a test cell, or an extract thereof, wherein the detecting methylation comprises:
contacting a nucleic acid molecule comprising the SOCS-1 of the test cell with bisulfite ions, whereby unmethylated cytosine residues in the SOCS-1 gene sequence are converted to bisulfite modified cytosine residues;
exposing the bisulfite ion treated SOCS-1 gene sequence to alkaline conditions, whereby bisulfite modified cytosine residues are converted to uracil residues; and
detecting the amount or distribution of uracil residues in the bisulfite ion treated SOCS-1 gene of the test cell, wherein detecting the amount or distribution of uracil residues comprises contacting the SOCS-1 gene sequence with a methylation-specific amplification primer pair and an unmethylation-specific amplification primer pair under conditions suitable for amplification,
wherein the methylation-specific amplification primer pair comprises a forward primer and a reverse primer, wherein at least one of the forward primer and the reverse primer comprises an oligonucleotide that selectively hybridizes to a SOCS-1 gene sequence containing cytosine residues, and wherein the unmethylation-specific amplification primer pair comprises a forward primer and a reverse primer, neither of which hybridizes to a SOCS-1 gene sequence containing cytosine residues
wherein an amplification product, if any, generated by the methylation-specific amplification primer pair has a first length, and wherein an amplification product, if any, generated by the unmethylation-specific amplification primer pair has a second length, which is different from the first length, whereby generation of an amplification product having the first length is indicative methylation of cytosine residues in CpG dinucleotides in the SOCS-1 gene of the test cell,
wherein a decrease in the amount or distribution of uracil residues in the SOCS-1 gene from the test cell, as compared to the amount or distribution of uracil residues in a corresponding bisulfite ion treated unmethylated SOCS-1 gene following exposure to alkaline conditions, is indicative of methylation of cytosine residues in CpG dinucleotides in the SOCS-1 gene of the test cell,
whereby said methylation results in a reduced level of transcription of the SOCS-1 gene in the test cell as compared to a corresponding normal cell,
thereby identifying the test cell as a neoplastic cell.

### Claim 17 (depends on 16)

The method of claim 16, wherein the methylation-specific amplification primer pair comprises SEQ ID NO:2 and SEQ ID NO:3.

### Claim 18 (depends on 16)

The method of claim 16, wherein the unmethylation-specific amplification primer pair comprises SEQ ID NO:4 and SEQ ID NO:5.

### Claim 19 (depends on 7)

The method of claim 7, wherein the sample is obtained from a subject.

### Claim 20 (depends on 19)

The method of claim 19, wherein the sample comprises an organ sample, a tissue sample, a cell sample, or a biological fluid.

### Claim 21 (depends on 7)

The method of claim 7, wherein the neoplastic cell is a cancer cell.

### Claim 22 (depends on 21)

The method of claim 21, wherein the cancer cell is a hepatocellular carcinoma cell, a multiple myeloma cell, or an acute leukemia cell.

### Claim at position 18

-40. (canceled)
